Flumetasone
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
|
|
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration |
Topical |
Pharmacokinetic data | |
Metabolism | Hepatic, CYP3A4-mediated |
Identifiers | |
CAS Number | 2135-17-3 ![]() |
ATC code | D07AB03 (WHO) , D07XB01 (combinations), QH02AB90 (WHO) |
PubChem | CID: 16490 |
UNII | LR3CD8SX89 ![]() |
KEGG | D04208 ![]() |
ChEMBL | CHEMBL1201392 ![]() |
Synonyms | Flumethasone |
Chemical data | |
Formula | C22H28F2O5 |
Molecular mass | 410.452 g/mol |
![]() ![]() |
Flumetasone (INN; or flumethasone) is a corticosteroid for topical use. Trade names include Locacorten, Locorten, and Orsalin. It is available in combination with clioquinol, under the trade name Locacorten-Vioform (in some countries Locorten-Vioform), for the treatment of otitis externa and otomycosis. It is usually formulated as the pivalic acid ester prodrug flumetasone pivalate.
Flumethasone is 420 times as potent as cortisone in an animal model for anti-inflammatory activity.[citation needed]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Articles with unsourced statements from September 2015
- Glucocorticoids
- Organofluorides
- Dermatologic drug stubs